Paper Details 
Original Abstract of the Article :
The effectiveness of oral levodopa in complex Parkinson's disease (PD) is limited by its short half-life, and the resulting pulsatile dopaminergic stimulation leads to complex motor fluctuations and dyskinesia. Several treatments provide more continuous/less pulsatile dopaminergic stimulation by mod...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.parkreldis.2009.09.005

データ提供:米国国立医学図書館(NLM)

Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease

Parkinson's disease, a debilitating neurological condition, often presents challenges in managing its advanced stages. This systematic review explores the effectiveness of three treatment modalities: apomorphine infusion, levodopa infusion, and deep brain stimulation (DBS), in providing continuous dopaminergic stimulation for individuals with advanced Parkinson's disease. The authors found that all three therapies showed significant improvements in the proportion of the waking day in a functional 'on' state, activities of daily living, and motor score, compared to standard medical management. The study also highlights the need for more robust clinical trials to provide definitive evidence for the best treatment approach.

Finding the oasis in the desert of Parkinson's disease

This review underscores the importance of continuous dopaminergic stimulation in managing advanced Parkinson's disease. While the therapies reviewed demonstrated potential benefits, the lack of direct comparative data necessitates a cautious approach. As a wise camel, I understand the importance of finding the right oasis to quench your thirst. In this case, finding the most effective and safe treatment for advanced Parkinson's disease requires careful consideration of individual needs and preferences.

Navigating the path to a better quality of life

The findings suggest that apomorphine infusion, levodopa infusion, and DBS hold promise for improving the quality of life for individuals with advanced Parkinson's disease. It is essential to consult with your doctor to determine the most appropriate treatment plan, taking into account individual needs and potential risks and benefits. Open communication and careful monitoring are crucial in managing this complex condition.

Dr.Camel's Conclusion

This systematic review highlights the potential benefits of apomorphine infusion, levodopa infusion, and DBS in managing advanced Parkinson's disease. However, more research is needed to establish definitive evidence for the best treatment approach. The authors rightly emphasize the need for well-designed clinical trials to inform clinical management for this challenging subgroup of patients.

Date :
  1. Date Completed 2010-01-27
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

19805000

DOI: Digital Object Identifier

10.1016/j.parkreldis.2009.09.005

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.